TDE2L Inhibitors
Chemical inhibitors of TDE2L function through various mechanisms to impede its activity. Staurosporine operates by obstructing the kinase activity essential for the phosphorylation of TDE2L, which is vital for its functional role within the cell. Similarly, Bisindolylmaleimide I specifically targets protein kinase C, which is implicated in the phosphorylation of a plethora of proteins, including TDE2L. By inhibiting this kinase, the phosphorylation, and consequent activation of TDE2L, is hindered. LY294002 and Wortmannin are both inhibitors of phosphoinositide 3-kinases (PI3K), and by thwarting PI3K, these inhibitors diminish the phosphorylation of proteins downstream in the PI3K pathway, which likely includes TDE2L, leading to a decrease in its activity.
In the MAPK/ERK pathway, PD98059 and U0126 both serve as MEK inhibitors, which can block the pathway, potentially preventing the phosphorylation and subsequent activation of TDE2L. SB203580, as a selective inhibitor of p38 MAP kinase, and SP600125, which impedes c-Jun N-terminal kinase (JNK), function to disrupt the phosphorylation states of proteins within their respective pathways, and this disruption can extend to TDE2L, resulting in its functional inhibition. PP2 and Dasatinib, by selectively inhibiting Src family tyrosine kinases and a spectrum of tyrosine kinases respectively, can reduce the phosphorylation of a range of substrates and prevent activation of TDE2L if it is within their substrate range. Imatinib targets tyrosine kinases like ABL, c-Kit, and PDGFR, and by inhibiting these kinases, it can decrease the phosphorylation and activity of TDE2L if it is influenced by these kinases. Lastly, Erlotinib, which inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase, can prevent the activation of downstream proteins that may be essential for the functional activity of TDE2L, thereby effectively inhibiting it.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. It can inhibit TDE2L by blocking the kinase activity required for the phosphorylation of TDE2L, thereby hindering its functional activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I selectively inhibits protein kinase C, which is involved in the phosphorylation of many proteins. By inhibiting PKC, it could prevent the phosphorylation and subsequent activation of TDE2L. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases. By inhibiting PI3K, it can reduce the phosphorylation of downstream proteins that may include TDE2L, leading to its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can prevent the phosphorylation of proteins in the PI3K pathway. This inhibition can extend to TDE2L, reducing its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can block the MAPK/ERK pathway. As this pathway can be responsible for the phosphorylation and activation of various proteins, inhibiting it could lead to reduced activity of TDE2L. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is also a MEK inhibitor and can inhibit the activation of MAPK/ERK pathway. By doing so, it may prevent the phosphorylation and activation of TDE2L. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase. By inhibiting p38 MAPK, it can reduce the phosphorylation of substrates involved in the same pathway as TDE2L, leading to its inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). Inhibition of JNK can affect the phosphorylation state of proteins within its pathway, potentially including TDE2L, and thus inhibit its activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family tyrosine kinases. Src kinases can phosphorylate a range of substrates, and inhibition of this family of kinases can lead to reduced activity of TDE2L if it is a substrate. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor that can inhibit multiple tyrosine kinases. This broad inhibition can prevent phosphorylation and activation of TDE2L if it is a tyrosine kinase substrate. | ||||||